期刊文献+

大败毒胶囊联合异维A酸治疗重度痤疮疗效观察 被引量:8

Clinical efficacy of Dabaidu Capsule combining with Isotretinoin in the treatment of severe acne
下载PDF
导出
摘要 目的观察大败毒胶囊联合异维A酸治疗重度痤疮的临床疗效。方法将入选的82例患者按就诊顺序分为治疗组和对照组,治疗组口服大败毒胶囊、泰尔丝;对照组仅口服泰尔丝。两组疗程均为8周。结果治疗组有效率为88.10%,对照组为62.50%;治疗组复发5例,对照组复发13例,两组患者的有效率和复发率比较,差异均有显著性意义(P均<0.05)。结论大败毒胶囊联合泰尔丝治疗重度痤疮疗效较好,复发率低。 Objective To investigate the efficacy of dabaidu capsule combining with isotretinoin in the treatment of severe acne. Methods Eighty-two patients with severe acne were divided into two groups randomly: Treatment group was administrated with dabaidu capsule and isotretinoin while Control group with isotretinoin only; Results In treatment group, the effective rate was 88.10%. In the control group, the effective rate was 62.50%, There was a significant difference in the effective rate between the two groups. Recurrence rate was 5/24 in treatment group and 13/14 in the control group; there was a significance difference in the recurrence rate between the two groups. Conclusion Compared with the control group, dabaidu capsule combi- ning with isotretinoin in the treatment of acne was more effective and has a lower recurrence rate.
作者 李瑞英 李铀
出处 《中国皮肤性病学杂志》 CAS 北大核心 2011年第7期573-574,共2页 The Chinese Journal of Dermatovenereology
关键词 大败毒胶囊 泰尔丝 重度痤疮 疗效观察 Dabaidu capsule Isotretinoin Severe acne Observation about curative effect
  • 相关文献

参考文献6

二级参考文献32

共引文献1479

同被引文献77

  • 1梁建宁,谭朝阳.大败毒胶囊质量标准研究[J].中国中医药信息杂志,2004,11(10):874-875. 被引量:6
  • 2刘永祥.痤疮可能相关发病因素调查[J].临床军医杂志,2004,32(5):113-114. 被引量:8
  • 3熊瑛.消痤汤联合异维A酸胶丸治疗重症痤疮的临床观察[J].山东医学高等专科学校学报,2006,28(6):423-425. 被引量:3
  • 4郑玉光,梁敏,刘翠艳,李国川,高艳芝.大败毒胶囊质量标准研究[J].中成药,2007,29(11):1700-1703. 被引量:2
  • 5刘渡舟著录.刘渡舟伤寒论讲稿[M].北京:人民卫生出版社,2008.1:324-325.
  • 6Manstein D,Herron G S,Sink R K,et al.Fractional photothermolysis:a new concept for cutaneous remodeling using microscopicpattems of thermal injury[J],Lasers SurgMed,2004,34(5):426-438.
  • 7Finlay A Y,Khan G K.Dermatology Life Quality index(DLQI)-a simple practical measure for routine clinical use[J],Clin Exp Dermatol,1994,19(3):210-216.
  • 8Hudgens S,Harper J C,Daniels S R,et al.Validation of a new patient-reported outcome measure for facial acne:The acne symptom and impact scale (ASIS)[J],J Drugs Dermatol,2014,13(3):333-340.
  • 9Antiga E, Verdelli A, Bonciani D, et al. Ache: a new model of immune-mediated chronic inflammatory skin disease [J]. G Ital Dermatol Venereol, 2015, 150 ( 2 ) : 247-254.
  • 10Das S, Reynolds R V. Recent advances in acne pathogenesis: implications for therapy [J]. Am J Clin Dermatol, 2014, 15 ( 6 ) : 479-488.

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部